<DOC>
	<DOCNO>NCT00206089</DOCNO>
	<brief_summary>This study carry study efficacy safety treatment melagatran injection follow ximelagatran tablet prevent blood clot , compare enoxaparin period 5-6 week . A separate visit , independent study do approximately 6 month surgery .</brief_summary>
	<brief_title>Melagatran/Ximelagatran Versus Enoxaparin Prevention Venous Thromboembolic Events</brief_title>
	<detailed_description />
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Melagatran</mesh_term>
	<mesh_term>Ximelagatran</mesh_term>
	<criteria>Signed informed consent , Female male age 18 year Patient schedule primary elective hip replacement patient require surgery hip fracture . History heparininduced thrombocytopenia Conditions associate increase risk bleeding , renal impairment , know active liver disease liver insufficiency . Myocardial infarction , Ischemic stroke Transient Ischemic Attack ( TIA ) , systemic embolism venous thromboembolism within 30 day enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Prevention venous thromboembolic event patient undergo elective hip replacement hip fracture surgery</keyword>
</DOC>